Cargando…

Molecular and Genetic Biomarkers in Idiopathic Pulmonary Fibrosis: Where Are We Now?

Idiopathic pulmonary fibrosis (IPF) represents a chronic progressive fibrotic interstitial lung disease of unknown cause with an ominous prognosis. It remains an unprecedent clinical challenge due to its delayed diagnosis and unpredictable clinical course. The need for accurate diagnostic, prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomos, Ioannis, Roussis, Ioannis, Matthaiou, Andreas M., Dimakou, Katerina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604739/ https://www.ncbi.nlm.nih.gov/pubmed/37893169 http://dx.doi.org/10.3390/biomedicines11102796

Ejemplares similares

Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be
por: Goos, Tinne, et al.
Publicado: (2021)

Genetics of migraine: where are we now?
por: Grangeon, Lou, et al.
Publicado: (2023)

Colorectal Cancer Biomarkers: Where Are We Now?
por: Gonzalez-Pons, Maria, et al.
Publicado: (2015)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Where are we now?
Publicado: (1977)

Genetic counseling globally: Where are we now?
por: Ormond, Kelly E., et al.
Publicado: (2018)

Association of Broad-Spectrum Antibiotic Therapy and Vitamin E Supplementation with Vitamin K Deficiency-Induced Coagulopathy: A Case Report and Narrative Review of the Literature
por: Matthaiou, Andreas M., et al.
Publicado: (2023)

Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go next
por: Mader, Reuven, et al.
Publicado: (2022)

Exercise-induced pulmonary hemorrhage: where are we now?
por: Poole, David C, et al.
Publicado: (2016)

The histologic diagnosis of usual interstitial pneumonia of idiopathic pulmonary fibrosis. Where we are and where we need to go
por: Smith, Maxwell L.
Publicado: (2021)

Correction: Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go next
Publicado: (2017)

Application of Machine Learning in Pulmonary Function Assessment Where Are We Now and Where Are We Going?
por: Giri, Paresh C., et al.
Publicado: (2021)

ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
por: Mejzini, Rita, et al.
Publicado: (2019)

Phenotypic and molecular basis for genetic variation in jelly palms (Butia sp.): where are we now and where are we headed to?
por: Cidón, Camila Fritzen, et al.
Publicado: (2023)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Review of Diagnostic Biomarkers in Autoimmune Pancreatitis: Where Are We Now?
por: Yokode, Masataka, et al.
Publicado: (2021)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Platelet-Rich Plasma: Where Are We Now and Where Are We Going?
por: Cole, Brian J., et al.
Publicado: (2010)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Ten Years for GHSP: Where Are We Now? Where Will We Go?
por: Bhutta, Zulfiqar A., et al.
Publicado: (2023)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

CAR-T cell therapy: Where are we now, and where are we heading?
por: Wang, Jia-Yi, et al.
Publicado: (2023)

Pulse Crop Genetics for a Sustainable Future: Where We Are Now and Where We Should Be Heading
por: Sahruzaini, Nurul Amylia, et al.
Publicado: (2020)

Long-term personal air pollution exposure and risk for acute exacerbation of idiopathic pulmonary fibrosis
por: Tomos, Ioannis, et al.
Publicado: (2021)

Aromatase inhibitors--where are we now?
por: Miller, W. R.
Publicado: (1996)

Depression research: where are we now?
por: Lee, Saebom, et al.
Publicado: (2010)

Personal workstations: Where are we now?
por: Willers, Ian Malcolm
Publicado: (1982)

Personal genomics: Where are we now?
por: Angrist, Misha
Publicado: (2016)

9. GFR - Where are We Now?
por: Delanghe, Joris R.
Publicado: (2009)

Calcaneal fractures: Where are we now?
por: Razik, Aisha, et al.
Publicado: (2017)

Intracranial Atherosclerosis: Where Are We Now?
por: Kim, Jong S.
Publicado: (2017)

Mindfulness in psychiatry – where are we now?
por: Groves, Paramabandhu
Publicado: (2016)

MHC Restriction: Where Are We Now?
por: Zareie, Pirooz, et al.
Publicado: (2020)

Microbiota and Obesity: Where Are We Now?
por: Ballini, Andrea, et al.
Publicado: (2020)

Pegfilgrastim Biosimilars: Where Are We Now?
por: Selby, Christopher, et al.
Publicado: (2021)

Hepatocellular adenoma: Where are we now?
por: Wang, Xi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kturhstvaec3rbf2f1atj4a04k